Cancer Institute A national cancer institute
designated cancer center

Department: Stanford Cancer Institute

W

  • Associate Professor of Medicine (Oncology) at the Stanford University Medical Center
    Member, Stanford Cancer Institute
    Clinical Focus
    • Thoracic Oncology
    • Lung Cancer - Medical Oncology
    • Investigational Therapeutics
    Research Interest

    Dr. Wakelee's research is focused on clinical trials in patients with lung cancer and other thoracic malignancies such as thymoma and thymic carcinoma. She also works with novel agents for all malignancies as part of the developmental therapeutics group of the cancer center. Other interests include translation projects in thoracic malignancies and collaborations with population scientists regarding lung cancer questions.

  • Professor of Materials Science and Engineering and of Electrical Engineering and, by courtesy, of Radiology
    Member, Bio-X
    Affiliate, Precourt Institute for Energy
    Member, Stanford Cancer Institute
    Member, Stanford Neurosciences Institute
    Affiliate, Stanford Woods Institute for the Environment
    Research Interest

    Dr. Wang is the Director of Stanford Center for Magnetic Nanotechnology, and the Co-PI of the Stanford Center for Cancer Nanotechnology Excellence. His research interests lie in nanotechnology and information storage, including magnetic/spintronic biochips, in vitro diagnostics, cell sorting, magnetic nanoparticles, nano-patterning, spin electronic materials and sensors, as well as magnetic integrated inductors and transformers.

  • Klaus Bensch Professor in Experimental Pathology, Emerita
    Member, Stanford Cancer Institute
    Research Interest

    The main focus of our research is to understand how cells maintain genome integrity by checkpoint mechanisms during chromosome replication.

  • Professor of Surgery (General Surgery) at the Stanford University Medical Center
    Member, Stanford Cancer Institute
    Clinical Focus
    • Breast Cancer
    • Breast Cancer  > Breast Cancer Clinical Trials
    • Breast Cancer
    Research Interest

    Clinical trials in operative procedures such as Nipple-sparing mastectomy, arm lymphatic mapping, skin perfusion and Treatments for Breast Cancer, especially local recurrence. Dr. Wapnir is institutional Principal Investigator and Chair for National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials. Laboratory and translational research includes exploring the activity of breast iodide transporter in breast cancer brain metastasis.

  • Ronald F. Dorfman, M.B.B.ch., FRCPath, Professor in Hematopathology, Emeritus
    Member, Stanford Cancer Institute
    Clinical Focus
    • Anatomic/Clinical Pathology
    • Pathology and Laboratory Medicine
    Research Interest

    As an Emeritus Professor, I no longer have a research laboratory and devote my half-time effort to lymphoma diagnosis and teaching. I do devote a small amount of effort to lymphoma research in collaboration with Yaso Natkunam and others in the Department of Pathology.

  • Anne T. and Robert M. Bass Professor in Pediatric Cancer and Blood Diseases
    Member, Stanford Cancer Institute
    Clinical Focus
    • Hematology, Pediatric
    • Oncology (Cancer), Pediatric
    • Pediatric Hematology-Oncology
  • William M. Hume Professor in the School of Medicine, Professor of Structural Biology, of Molecular and Cellular Physiology and of Photon Science
    Member, Bio-X
    Member, Stanford Cancer Institute
    Faculty Fellow, Stanford ChEM-H
    Research Interest

    Our laboratory studies molecular interactions that underlie the establishment and maintenance of cell and tissue structure. Our specific areas of interest are the architecture and dynamics of intercellular adhesion junctions, the molecular basis of cell polarity, and the Wnt signaling pathway. We also have a long-standing interest in carbohydrate-based cellular recognition and adhesion.

  • Virginia & D.K. Ludwig Professor for Clinical Investigation in Cancer Research, Professor of Developmental Biology &, by courtesy, of Biology
    Member, Bio-X
    Member, Stanford Cancer Institute
    Research Interest

    Stem cell and cancer stem cell biology; development of T and B lymphocytes; cell-surface receptors for oncornaviruses in leukemia. Hematopoietic stem cells; Lymphocyte homing, lymphoma invasiveness and metastasis.

  • Harry A. Oberhelman, Jr. Professor
    Member, Stanford Cancer Institute
    Clinical Focus
    • GI Oncology
    • Anal Cancer
    • Basal / Squamous Cell Carcinomas
    Research Interest

    Clinical research focused on the diagnosis, prevention and treatment of anal cancer and its precursor lesions. Clinical trials of ablative therapy for High-grade Squamous Intraepithelial Lesions (HSIL) of the anus and perianal tissues as a means for preventing anal cancer.
    Basic science work in collaboration with Ronald Davis and Hanlee Ji focused on the molecular genetic and pathologic studies of anal cancers using moecular inversion probe genomic technology

  • Francis W. Bergstrom Professor of Chemistry and Professor, by courtesy, of Chemical and Systems Biology
    Member, Bio-X
    Member, Stanford Cancer Institute
    Faculty Fellow, Stanford ChEM-H
    Research Interest

    Molecular imaging, therapeutics, drug delivery, drug mode of action

  • Assistant Professor of Medicine (Blood and Marrow Transplantation) and, by courtesy, of Dermatology at the Stanford University Medical Center
    Member, Stanford Cancer Institute
    Clinical Focus
    • Blood and Marrow Transplant
    • Lymphoma
    • Cutaneous T-Cell Lymphoma
    Research Interest

    My research interest is on immunotherapy (including allogeneic transplant) of cancer. I have studies the mechanism of monoclonal antibody therapy in lymphoma patients and am currently working on designing new strategy to enhance the clinical efficacy of antibody therapy by infusing expanded NK cells. I am also interested in using tumor vaccine along with hematopoietic cell transplant.

  • Assistant Professor of Pathology
    Member, Bio-X
    Member, Child Health Research Institute
    Member, Stanford Cancer Institute
    Member, Stanford Neurosciences Institute
    Research Interest

    Epigenetic Reprogramming, Direct conversion of fibroblasts into neurons, Pluripotent Stem Cells, Neural Differentiation: implications in development and regenerative medicine

  • Associate Professor of Pathology at the Stanford University Medical Center
    Member, Bio-X
    Member, Stanford Cancer Institute
    Clinical Focus
    • Pathology and Laboratory Medicine
    • Breast Cancer
    • Sarcoma
    Research Interest

    My laboratory studies the molecular events that lead to and sustain tumorigenesis in soft tissue tumors and epithelial cancers. We also have an interest in stromal reaction patterns in the microenvironment of cancer.

  • Associate Professor of Obstetrics and Gynecology (Reproductive Endocrinology and Infertility) at Stanford University Medical Center
    Member, Bio-X
    Member, Stanford Cancer Institute
    Clinical Focus
    • Fertility (Reproductive Medicine)
    • Gynecology
    • Reprod. Endocrinology and Infertility
    Research Interest

    Infertility, fertility preservation, oocyte cryopreservation

  • Professor of Health Research and Policy
    Member, Stanford Cancer Institute
    Research Interest

    Cancers of the prostate, breast and ovary account for a major proportion of new cancer cases and cancer deaths in the U.S. each year. Our recent research focus has been on developing improved statistical methods for the design and conduct of studies involving hereditary predisposition and modifiable lifestyle characteristics in the etiologies of site-specific cancers.

  • Associate Professor of Radiology (General Radiology)
    Member, Bio-X
    Member, Stanford Cancer Institute
    Clinical Focus
    • Diagnostic Radiology
    • Abdominal and Pelvic Imaging
    Research Interest

    Willmann lab focuses on the development and clinical translation of novel molecular and functional imaging strategies with special focus on abdominal and pelvic diseases.

  • Assistant Professor of Genetics and of Pathology
    Member, Bio-X
    Member, Stanford Cancer Institute
    Research Interest

    Our laboratory uses genome-wide methods to uncover alterations that drive cancer progression and metastasis in genetically-engineered mouse models of human cancers. We combine cell-culture based mechanistic studies with our ability to alter pathways of interest during tumor progression in vivo to better understand each step of metastatic spread and to uncover the therapeutic vulnerabilities of advanced cancer cells.

  • Professor of Neurosurgery
    Member, Stanford Cancer Institute
    Research Interest

    Our goal is to define targets for cancer therapeutics by identifying alterations in signal transduction proteins. We first identified a naturally occurring mutant EGF receptor (EGFRvIII) and then delineated its unique signal transduction pathway. This work led to the identification of Gab1 followed by the discovery that JNK is constitutively active in tumors. We intiated using altered proteins as the target for vaccination, where an EGFRvIII based vaccine appears to be highly effective.

  • Stephen R. Pierce Family Goldman Sachs Professor in Science and Human Health, Professor of Health Research and Policy and, by courtesy, of Biology
    Member, Bio-X
    Member, Stanford Cancer Institute
    Research Interest

    Current interest centers on the application of statistics to problems arsing from biology. We are particularly interested in questions concerning gene regulation and signal transduction.

  • Professor of Medicine (Cardiovascular) and of Radiology
    Member, Bio-X
    Member, Stanford Cancer Institute
    Faculty Fellow, Stanford ChEM-H
    Clinical Focus
    • Congenital Heart Disease (Adult)
    • Cardiovascular Disease
    Research Interest

    Drug discovery, drug screening, and disease modeling using biobank of cardiac iPSC lines.

  • Assistant Professor of Medicine (Endocrinology)
    Member, Stanford Cancer Institute
    Clinical Focus
    • Osteoporosis
    • Metabolic Bone Disease
    • Endocrinology
    Research Interest

    My laboratory focuses on the pathways that regulate the differentiation of mesenchymal stem cells into the osteoblast and adipocyte lineages. We are also studying the role of osteoblasts in the hematopoietic stem cell niche and B lymphocyte development in the bone marrow microenvironment.

  • Associate Professor of Chemical and Systems Biology and of Developmental Biology
    Member, Stanford Cancer Institute
    Research Interest

    Research in our lab focuses on mechanisms of epigenetic regulation in differentiation and development. In particular, we are studying the function of histone modifying enzymes in embryonic stem cell self-renewal and in early cell fate decisions. We are interested in the role of chromatin modifications in establishment and maintenance of gene expression patterns during normal and pathological development, and in nuclear reprogramming.

Stanford Medicine Resources:

Footer Links: